Younes, Y., Shaheen, Y., El Feky, H., Omar, M., Eldesouky, R., Amer, R., Mabrouk, R. (2015). Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy. test, 5(2), 69-77. doi: 10.21608/aeji.2015.17815
Yehia S Younes; Yasser Shaheen; Hala El Feky; Maha Omar; Rasha SH Eldesouky; Rania Z Amer; Rania I Mabrouk. "Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy". test, 5, 2, 2015, 69-77. doi: 10.21608/aeji.2015.17815
Younes, Y., Shaheen, Y., El Feky, H., Omar, M., Eldesouky, R., Amer, R., Mabrouk, R. (2015). 'Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy', test, 5(2), pp. 69-77. doi: 10.21608/aeji.2015.17815
Younes, Y., Shaheen, Y., El Feky, H., Omar, M., Eldesouky, R., Amer, R., Mabrouk, R. Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy. test, 2015; 5(2): 69-77. doi: 10.21608/aeji.2015.17815

Antinuclear Antibody Positivity in Chronic Hepatitis C Patients: Effect on Histopathology and Impact on Early Response to Combined Antiviral Therapy

Afro-Egyptian Journal of Infectious and Endemic Diseases
Article 3, Volume 5, Issue 2, June 2015, Pages 69-77    PDF (318.37 K)
Document Type: Original Article
DOI: 10.21608/aeji.2015.17815
Authors
Yehia S Younes1; Yasser Shaheen1; Hala El Feky1; Maha Omar1; Rasha SH Eldesouky2; Rania Z Amer3; Rania I Mabrouk4
1Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine, Benha University,Egypt.
2Community Medicine Department, Faculty of Medicine, Benha University,Egypt.
3Pathology Department, Faculty of Medicine, Benha University,Egypt.
4Shebin El-Kom Teaching Hospital , Shebin El-Kom,Egypt
Abstract
Background and study aim : The prevalence of antinuclear antibody (ANA) has been documented in patients with hepatitis C virus (HCV) infection. Hepatitis C virus infection plays an important role in the pathogenesis of immunological derangement, but the mechanism remains unclear. The aim of this study is to detect the significance of ANA positivity and its impact on histopathology and early virological response (EVR) to combined antiviral therapy in chronic HCV patients. .
Patients and Methods:Two hundred Egyptian chronic HCV naïve patients were enrolled in this study. Antinuclear antibody (ANA) was detected by ELISA and it was considered positive with a titer > 1 : 14 by indirect immunofluorescence. Complete laboratory investigations and histological examination were done as a pretreatment work up for all patients. Patients were followed up during treatment and EVR was assessed in ANA positive and negative patients.
Results: There was a statistically significant difference between ANA positive and negative patients regarding viral load and histopathological criteria and no significant difference was detected regarding other demographic and laboratory criteria. EVR was close in ANA positive and ANA negative patients (77 for the former Vs. 80 for the later with P = 0.33). No autoimmune manifestations were detected during treatment among positive cases. Except for ALT & AST levels no statistically significant differences were detected between ANA positive and negative cases regarding haematological data, thyroid dysfunction. BMI, ALT levels, viral load and fibrosis stages were independent predictors of EVR.
Conclusion: ANA postivity in chronic HCV patients was associated with advanced fibrosis but didn't affect treatment response.
Keywords
Antinuclear Antibody (ANA ); Interferon (IFN); Early Virological Response (EVR)
Statistics
Article View: 186
PDF Download: 441